跳至主要内容
临床试验/NCT02053766
NCT02053766终止不适用

Anesthesia in Patients With Mitochondrial Disease

The University of Texas Health Science Center, Houston1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2014年1月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
19
试验地点
1
主要终点
Number of Participants Who Experienced an Adverse Event

研究概览

简要总结

This pilot study is a prospective, randomized clinical trial to evaluate the effect of anesthesia in the mitochondrial dysfunction patient.

详细描述

Study subjects undergoing a routine medical care non-emergent procedure will be randomized into three different groups to receive one of the following anesthetic agents; Sevoflurane, Propofol or Dexmedetomidine.

The primary outcome of this pilot study is to evaluate and compare the incidence of adverse events in mitochondrial patients undergoing a diagnostic or therapeutic procedure up to 48 hours post anesthesia. The secondary outcome is to compare the metabolic derangements between three study groups by comparing changes in blood sugar, serum pH, serum bicarbonate, serum lactate and serum pyruvate levels before, during and after anesthesia in the groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
1 Day 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Subjects must fulfill the following inclusion criteria:
  • Subject is informed and given ample opportunity to consider his/her participation and has given his/her written consent.
  • Subject is willing and able to comply with all study requirements.
  • Subject is between 0 - 17 years of age.
  • Subject has been diagnosed with mitochondrial dysfunction based on modified Walker criteria.
  • Subject is scheduled to have a non-emergent diagnostic or therapeutic procedure for routine medical care requiring general anesthesia estimated to last at least one hour.
  • Subject is classified ASA I - IV

排除标准

  • Subjects are not permitted to enroll in the study if any of the following criteria are met:
  • Subject is older than 17 years
  • Subject is pregnant
  • Subject is a nursing female and
  • Subject has participated in the same study within 48 hours
  • Subject is allergic or has had any adverse effect to any of the study agents in the past
  • Anesthesia time is less than one hour
  • Subject is classified ASA V

研究组 & 干预措施

Sevoflurane

Active Comparator

In the Operating Room (OR) after applying routine monitors, anesthesia will be induced with a mask using Sevoflurane up to 8%. Sevoflurane will be used for maintenance for the rest of the procedure with dosage between 1.5% and 4%. Vitals will be monitored. Fentanyl will be used as needed. Rocuronium will be used as needed for muscle relaxation. At the end of the procedure twitches will be evaluated and muscle relaxation will be reversed. Sevoflurane will be turned off at the end of procedure.

干预措施: Sevoflurane (Drug)

Dexmedetomidine (Precedex®)

Active Comparator

These subjects will receive Dexmedetomidine intravenously. In the OR routine monitors will be placed. Vitals will be monitored. A loading dose of Precedex 1mcg/ kg will be given over 10 minutes. Infusion will be started using Precedex 1mcg/ kg/ hr and can be increased or decreased as needed. Fentanyl will be used as needed. Rocuronium will be used as needed for muscle relaxation. At the end of the procedure twitches will be evaluated and muscle relaxation will be reversed. Precedex infusion will be stopped at the end of the procedure.

干预措施: Dexmedetomidine (Drug)

Propofol

Active Comparator

These subjects will receive propofol for anesthesia maintenance. In the OR routine monitors will be placed. Vitals will be monitored. A loading dose of Propofol 2mg/ kg will be given over 2 minutes. Infusion will be started using Propofol 50 mcg/ kg/min and can be increased or decreased as needed (range 50-300mcg/kg/min). Fentanyl will be used as needed. Rocuronium will be used as needed for muscle relaxation. At the end of the procedure twitches will be evaluated and muscle relaxation will be reversed. Propofol infusion will be stopped at the end of the procedure.

干预措施: Propofol (Drug)

结局指标

主要结局

Number of Participants Who Experienced an Adverse Event

时间窗: Up to 48 hours post anesthesia.

次要结局

  • Serum Pyruvate(24 hours post-operative)
  • Serum pH(24 hours post-operative)
  • Blood Glucose Level(24 hours post-operative)
  • Serum Bicarbonate(24 hours post-operative)
  • Serum Lactate(24 hours post-operative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria Matuszczak

◦Professor of Anesthesiology-Clinical

The University of Texas Health Science Center, Houston

研究点 (1)

Loading locations...

相似试验

Anesthesia in Patients With Mitochondrial Disease | 临床试验